Gayle Robert Dolecek
Director/Miembro de la Junta en Sucampo Pharma Europe Ltd. .
Perfil
Gayle Robert Dolecek is currently a Director at Sucampo Pharma Europe Ltd.
and a Professor at Parenteral Drug Association.
Previously, Gayle was a Director and SVP-Research & Development at Sucampo Pharmaceuticals, Inc. from 2006 to 2011, and a Director-Compendial Operations at the Center for Drug Evaluation & Research.
Gayle received a graduate degree from the University of Hawai'i at Hilo and undergraduate and doctorate degrees from the University of Maryland.
Cargos activos de Gayle Robert Dolecek
| Empresas | Cargo | Inicio |
|---|---|---|
| Parenteral Drug Association | Corporate Officer/Principal | - |
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Director/Miembro de la Junta | 07/08/2008 |
Antiguos cargos conocidos de Gayle Robert Dolecek.
| Empresas | Cargo | Fin |
|---|---|---|
| Center for Drug Evaluation & Research | Corporate Officer/Principal | - |
| SUCAMPO PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 15/11/2011 |
Formación de Gayle Robert Dolecek.
| University of Maryland | Doctorate Degree |
| University of Hawai'i at Hilo | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
| Parenteral Drug Association | |
| Center for Drug Evaluation & Research | Government |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
- Bolsa de valores
- Insiders
- Gayle Robert Dolecek